PaperWorks Industries has invested $3 million in a new warehouse for its Wabash, Indiana paperboard mill. The new facility is expected to be operational during the first quarter of 2018. The 44,500 square foot addition to the company's existing mill will be capable of storing up to 7,000 tons of coated recycled board (CRB) rolls. The mill produces PaperWorks' recently launched MasterWorks Ultra 100 line, as well as other CRB grades. "Over the past three years, PaperWorks has invested more than 60 million dollars to upgrade its paperboard mills and folding carton converting plants. This latest investment is designed to lower costs, improve service and reduce our environmental footprint at this location," said Andy Bolton, president and chief executive officer. Click Read More below for additional information.

The Biodegradable Products Institute is focusing on bringing more clarity to compostable packaging’s future in California, dually advocating for rulemaking at USDA as well as new state legislation. At a meeting last week, the U.S. Department of Agriculture’s National Organic Standards Board recommended against unanimously against adding synthetic compostable materials as compost feedstocks to the National List of Allowed and Prohibited Substances. How the board got to that vote was a multi-year process. USDA determinations on what’s allowed in organic compost would hold notable weight in California. Under California’s 2021 compostables law AB 1201, products labeled “compostable” would have to be an allowable agricultural organic input under the requirements of USDA’s National Organic Program.

Virox Technologies Inc., a leading innovator of patented, sustainable disinfectant chemistries, today announces that it has finalized multi-year licensing and supply agreements with Diversey, A Solenis Company, to bring its latest patented disinfectant technology, Citr-IQTM, to the healthcare sector and others. Diversey is a leading provider of hygiene, infection prevention and cleaning products, and technology, and will add multiple disinfectant products, powered by Virox’s Citr-IQ, to its lineup of professional offerings. Under the terms of the agreements, Virox will receive undisclosed license fees and royalties for the use of the formulas covered under the patented Citr-IQ disinfectant platform, as well as manufacture products containing the Citr-IQ formulas for Diversey’s North American markets. These Citr-IQ products will be produced in Virox’s LEED® Gold Certified manufacturing facility in Oakville, Ontario, Canada. Diversey has previously licensed chemical disinfectant technology from Virox with the patented Accelerated Hydrogen Peroxide® (AHP®) platform, which Diversey fully acquired from Virox in 2019. AHP was created by Virox in 1998, and successfully transformed disinfection with a safe, effective, and sustainable patented chemistry. AHP is used across the globe in human and animal health sectors and is the active ingredient in multiple brands, including Diversey’s Oxivir® and Accel® infection prevention platforms.